These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 132372)

  • 21. The biochemistry of complement.
    Porter RR; Reid KB
    Nature; 1978 Oct; 275(5682):699-704. PubMed ID: 703835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoglobulin and complement deposits in lupus glomerulonephritis.
    Méry JP; Morel-Maroger L; Boelaert J
    Proc Eur Dial Transplant Assoc; 1975; 11():506-11. PubMed ID: 1197274
    [No Abstract]   [Full Text] [Related]  

  • 23. Activation of the complement and properdin systems in rheumatoid arthritis.
    Ruddy S; Austen KF
    Ann N Y Acad Sci; 1975 Jun; 256():96-104. PubMed ID: 1099964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative analysis of the C1-binding ability of fragments derived from complement-fixing and noncomplement-fixing IgM proteins.
    Hurst MM; Volanakis JE; Stroud RM; Bennett JC
    J Clin Invest; 1976 Jul; 58(1):16-21. PubMed ID: 932203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The eleventh Hopkins Memorial Lecture: The biochemistry of complement.
    Porter RR
    Biochem Soc Trans; 1977; 5(6):1659-74. PubMed ID: 340299
    [No Abstract]   [Full Text] [Related]  

  • 26. The structure and mechanism of activation of the first component of complement.
    Reid KB; Porter RR
    Contemp Top Mol Immunol; 1975; 4():1-22. PubMed ID: 1104255
    [No Abstract]   [Full Text] [Related]  

  • 27. [Complement fixation activity of immunoglobulin G in ethylene glycol solutions].
    Tétin SIu; Efetov KA; Troitskiĭ GV; Kozlov LV; Zinchenko AA
    Bioorg Khim; 1985 Aug; 11(8):1068-73. PubMed ID: 4062991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of direct binding of enzyme-conjugated antihuman IgG t C1q using dextran sulphate in solid phase assays for immune complexes.
    Gripenberg M; Rhen M; Hautanen A; Linder E
    J Clin Pathol; 1982 May; 35(5):581-2. PubMed ID: 6177719
    [No Abstract]   [Full Text] [Related]  

  • 29. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
    Antón LC; Alcolea JM; Sánchez-Corral P; Marqués G; Sánchez A; Vivanco F
    Biochem J; 1989 Feb; 257(3):831-8. PubMed ID: 2784671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of the classical and alternative pathways of complement fixation by immune complexes containing normal and tryptophan-modified immunoglobulin G.
    Rodrick M; Allan R; Isliker H
    J Immunol Methods; 1978; 22(3-4):211-8. PubMed ID: 567237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the role of tyrosine residues in human IgG and rabbit IgG in binding of complement subcomponent C1q.
    McCall MN; Easterbrook-Smith SB
    Biochem J; 1989 Feb; 257(3):845-51. PubMed ID: 2784672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible binding of a T cell factor on IgG-coated sepharose beads.
    Guimezanes A; Fridman WH; Gisler RH; Kourilsky FM
    Eur J Immunol; 1976 Jan; 6(1):69-72. PubMed ID: 971721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autocatalytic activation of the proenzyme form of the C1s subunit of the first component of complement.
    Morgan PH; Nair IG
    Biochem Biophys Res Commun; 1975 Oct; 66(3):1037-41. PubMed ID: 1180942
    [No Abstract]   [Full Text] [Related]  

  • 35. Effector activating determinants on IgG. II. Differentiation of the combining sites for C1q from those for cytotoxic K cells and neutrophils by plasmin digestion of rabbits IgG.
    MacLennan IC; Connell GE; Gotch FM
    Immunology; 1974 Feb; 26(2):303-10. PubMed ID: 4277464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and activation of the early components of complement.
    Porter RR
    Fed Proc; 1977 Aug; 36(9):2191-6. PubMed ID: 328305
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune complex mediated activation of the classical complement pathway.
    Borsos T
    Behring Inst Mitt; 1989 Jul; (84):93-101. PubMed ID: 2478118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of latent collagenase by serum proteinases that interact with immobilized immunoglobulin G.
    Armour PC; Levi S; Golds EE; Poole AR; Mort JS; Roughley PJ
    Rheumatol Int; 1984; 4(4):151-5. PubMed ID: 6091234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.
    Wallace EM; Perkins SJ; Sim RB; Willis AC; Feighery C; Jackson J
    Mol Med; 1997 Jun; 3(6):385-96. PubMed ID: 9234243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The presence of histidine residues at or near the C1q binding site of rabbit immunoglobulin G.
    McCall MN; Easterbrook-Smith SB
    Biochim Biophys Acta; 1987 Mar; 912(1):9-15. PubMed ID: 3493808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.